Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".

Tapp LD, Lip GYH, Lane DA.

Chest. 2011 Feb;139(2):240-243. doi: 10.1378/chest.10-1102. No abstract available.

PMID:
21285051
2.

"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.

Zhao HJ, Zheng ZT, Wang ZH, Li SH, Zhang Y, Zhong M, Zhang W.

Chest. 2011 Feb;139(2):260-270. doi: 10.1378/chest.09-3083.

PMID:
21285053
3.

Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.

Barbieri L, Verdoia M, Schaffer A, Suryapranata H, De Luca G.

Cardiovasc Drugs Ther. 2016 Dec;30(6):611-622.

PMID:
27757726
4.

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.

Lopes RD, Rao M, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey P, Piccini JP, Singer DE, Chang P, Peterson ED, Mahaffey KW.

Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.

5.

Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.

Helft G, Gilard M, Le Feuvre C, Zaman AG.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):673-80. Review.

PMID:
17122800
6.

Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.

[No authors listed]

Prescrire Int. 2009 Dec;18(104):272-3. No abstract available.

PMID:
20027714
7.

[Preventing cerebrovascular accidents during atrial fibrillation].

Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A.

Presse Med. 2005 Oct 22;34(18):1315-24. Review. French.

PMID:
16269996
8.

Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.

Pipilis A, Lazaros G, Tsakonas G, Stefanadis C.

Hellenic J Cardiol. 2010 Jul-Aug;51(4):330-7. Review. No abstract available.

10.

Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.

Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX.

Int J Cardiol. 2011 Apr 1;148(1):96-101. doi: 10.1016/j.ijcard.2010.11.019. Epub 2010 Dec 23. Review.

PMID:
21185095
11.

[Anticoagulation and antiaggregation in neurological patients].

Arnold M, Nedeltchev K, Mattle HP.

Ther Umsch. 2003 Jan;60(1):33-5. German.

PMID:
12638476
12.

Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.

Enomoto Y, Iijima R, Tokue M, Ito N, Nagashima Y, Araki T, Yamazaki K, Utsunomiya M, Hori M, Itaya H, Shiba M, Hara H, Nakamura M, Sugi K.

Cardiovasc Interv Ther. 2014 Jul;29(3):193-9. doi: 10.1007/s12928-013-0234-4. Epub 2013 Dec 24.

PMID:
24366503
13.

Triple therapy: triple safety or triple danger?

Dewilde W, Breet N, Ten Berg J.

Am J Cardiol. 2010 Feb 15;105(4):579. doi: 10.1016/j.amjcard.2009.09.051. No abstract available.

PMID:
20152257
14.

When guidelines collide...

Spencer FA, Becker RC.

Am Heart J. 2004 Mar;147(3):395-7. No abstract available.

PMID:
14999185
15.

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.

Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S.

J Card Fail. 2004 Apr;10(2):101-12.

PMID:
15101020
16.

Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.

Suh SY, Kang WC, Oh PC, Choi H, Moon CI, Lee K, Han SH, Ahn T, Choi IS, Shin EK.

Heart Vessels. 2014 Sep;29(5):578-83. doi: 10.1007/s00380-013-0399-x. Epub 2013 Aug 24.

PMID:
23974943
17.

[When ASS, when anticoagulants?].

[No authors listed]

MMW Fortschr Med. 2006 Aug 17;148(33-34):55. German. No abstract available.

PMID:
16981391
18.

Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.

Faza NN, Mentias A, Parashar A, Chaudhury P, Barakat AF, Agarwal S, Wayangankar S, Ellis SG, Murat Tuzcu E, Kapadia SR.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):E64-E74. doi: 10.1002/ccd.26574. Epub 2016 May 24.

PMID:
27220088
19.

Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.

Sarafoff N, Ndrepepa G, Mehilli J, Dörrler K, Schulz S, Iijima R, Byrne R, Schömig A, Kastrati A.

J Intern Med. 2008 Nov;264(5):472-80. doi: 10.1111/j.1365-2796.2008.01989.x. Epub 2008 Jun 25.

20.

[Anticoagulation and antiaggregation in cardiac patients].

Meyer BJ.

Ther Umsch. 2003 Jan;60(1):27-32. German.

PMID:
12638475

Supplemental Content

Support Center